California Medical Clinic for Headache

Santa Monica, California 90404

0 studies enrolling now · 33 studies all time

What they study most

Acute Migraine, Acute Treatment of Migraine, Alzheimer's Disease, Aura, Bilateral Nasal Polyposis, Chronic Cluster Headache, Chronic Migraine, Cluster Headache, Episodic Cluster Headache, Episodic Migraine, Headache (Migraine), Headache Disorders

Studies at this site

• Evaluation of Treatment Satisfaction and Preference for Sumavel DosePro in the Treatment of Migraine — Completed
• Long-term Safety Study of BHV-3500 (Zavegepant*) for the Acute Treatment of Migraine — Completed
• Dose Ranging Study of Rimegepant (BMS-927711) for the Acute Treatment of Migraine — Completed
• Safety and Efficacy Study in Adult Subjects With Acute Migraines — Completed
• Open Label Safety Study in Acute Treatment of Migraine — Completed
• Double-Blind Comparison of the Efficacy and Safety of C213 to Placebo for the Acute Treatment of Cluster Headaches — Completed
• A Study of LY2951742 (Galcanezumab) in Participants With Cluster Headache — Completed
• Study to Evaluate the Safety and Tolerability of Treatment With Atogepant 60 mg Daily for the Prevention of Migraine in Participants With Episodic Migraine — Completed
• Safety and Efficacy of NPS 1776 in the Acute Treatment of Migraine Headaches — Completed
• Efficacy and Safety of Nerivio Device for Acute Treatment of Migraine in People With Chronic Migraine — Completed
• Non-invasive Vagus Nerve Stimulation for the Prevention of Migraines — Completed
• A Study of Galcanezumab in Participants With Chronic Cluster Headache — Completed
• Follow up 18F-AV-1451 Scan in Confirmatory Cohort Subjects From Study 18F-AV-1451-A05 — Completed
• A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine — Completed
• A Safety Study of Galcanezumab in Participants With Migraine, With or Without Aura — Completed
• Non-invasive Neurostimulation of the Vagus Nerve for the Treatment of Cluster Headache — Completed
• A Study Of Galcanezumab In Participants With Episodic Cluster Headache — Completed
• An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine — Completed
• Study Evaluating the Efficacy and Safety of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate Twice a Day (BID) Using a Novel Bi Directional Device in Subjects With Bilateral Nasal Polyposis Followed by an 8-Week Open-Label Extension Phase to Assess Safety — Completed
• A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache — Completed
• Two Dose Levels of DFN-15 vs. Placebo in Patients With Migraine Headaches — Completed
• Safety and Efficacy of ZP-Zolmitriptan Intracutaneous Microneedle Systems for the Acute Treatment of Migraine — Completed
• DFN-02 Open Label Safety Study in Patients With Acute Migraine — Completed
• Staccato Prochlorperazine in Migraine (Out Patient) — Completed
• Efficacy and Safety of 20 mg Sumatriptan Powder Delivered Intranasally With the Bi-directional Device Compared With 100 mg Sumatriptan Tablets in Adults With Acute Migraine With or Without Aura — Completed
• Civamide Nasal Solution for Postherpetic Neuralgia of the Trigeminal Nerve — Stopped early
• Safety & Efficacy of a Single Dose of Sumatriptan Powder Delivered Intranasally With the Bi-directional Device in Adults With Acute Migraine — Completed
• Study of NXN 188 for the Treatment of Migraine With Aura — Completed
• Study of Lornoxicam or Placebo for Acute Treatment of the Headache of Migraine. — Completed
• A Phase III Study of Civamide Nasal Solution (Zucapsaicin) for the Treatment of Episodic Cluster Headache — Completed
• Intranasal Civamide for Episodic Cluster Headache — Completed
• Preventive Treatment of Episodic and Chronic Migraine — Status unconfirmed
• Zolmitriptan Nasal Spray Versus Eletriptan in the Acute Treatment of Migraine — Completed